99P Impact of single-heterozygous UGT1A1 on the clinical outcomes of nano-liposomal irinotecan plus 5-fluorouracil/leucovorin for patients with pancreatic ductal adenocarcinoma

Autor: Harada, K., Yamamura, T., Muto, O., Nakamura, M., Sogabe, S., Sawada, K., Nakano, S., Yagisawa, M., Muranaka, T., Dazai, M., Tateyama, M., Kobayashi, Y., Kato, S., Miyagishima, T., Kawamoto, Y., Yuki, S., Sakata, Y., Sakamoto, N., Komatsu, Y.
Zdroj: In Annals of Oncology November 2022 33 Supplement 9:S1473-S1473
Databáze: ScienceDirect